MS Nursing: Listening, Leadership, and the Role of AI in Patient Care
At every stage of the MS journey, nurses are the steady link between patients, families, and the healthcare team. In this episode, host Brett Drummond speaks with Amy Perrin Ross, MS Specialist Nurse and Program Coordinator at Loyola University Chicago (USA), and Miguel Ángel Cortés-Vicente, Multiple Sclerosis Consultant Nurse at CEMCAT – Centre d'Esclerosi Múltiple de Catalunya (Spain), about the evolving role of MS nurses — from care coordination and patient engagement to leadership in research and innovation. They share insights from the 2025 ECTRIMS Congress Nurse Sessions, exploring how nurses are advancing health literacy, supporting shared decision-making, and integrating AI to improve patient care.
--------
25:07
--------
25:07
Why We Need to Talk More About Mental Health in MS
While much of MS care focuses on physical symptoms, mental health challenges—like depression, anxiety, loneliness, and stigma—often go under-recognised. In this episode, host Brett Drummond speaks with Dr. Rebecca MaGuire, psychologist and MS researcher at Maynooth University, who also lives with MS herself. Together they discuss why mental health must become a core part of MS care, what the latest research reveals, and how clinicians and communities can better support emotional wellbeing throughout the MS journey.
--------
20:32
--------
20:32
Patient Community Day 2025
Patient Community Day 2025 set a new attendance record, highlighting the growing desire among people living with MS to connect with experts leading the charge in understanding the disease and advancing effective treatments. After the event wrapped up in Barcelona, host Brett Drummond caught up with Julie Petrin, Director of Impact and Evaluation at MS Canada and a person living with MS, and Non Helena Smit, CEO of MS South Africa, to reflect on key takeaways and share what they're looking forward to at next year's event in Toronto.
--------
21:45
--------
21:45
Positive Remyelination Trial Results: Late Breaking at ECTRIMS 2025
At the late breaking abstracts session at ECTRIMS 2025 in Barcelona, the CCMR-Two trial revealed promising results for myelin repair in MS using the diabetes drug metformin and the antihistamine clemastine. Straight from his presentation, trial lead Dr. Nick Cunniffe of the University of Cambridge sat down with host Brett Drummond of MStranslate to discuss the full results of CCMR-Two, our current understanding of myelin repair biology, and the next steps for remyelination clinical trials and potential future MS therapies.
--------
25:19
--------
25:19
Final Day Highlights of ECTRIMS 2025
On the final day of ECTRIMS 2025 in Barcelona, the spotlight turned to MS treatment, including long-awaited clinical trial results. Dr. Sharmilee Gnanapavan, Consultant Neurologist at Barts Health and Princess Alexandra Hospital NHS Trust (UK), joins host Brett Drummond to reflect on key takeaways from the 41st Congress and what the MS community might look forward to at MSToronto 2026.
The world is better when its people are connected. The ECTRIMS Podcast aims to be a sounding board for MS experts & advocates to discuss innovative work in MS research, treatment and care with the greater MS research community, while offering a collaborative platform for MS and healthcare experts to promote & nurture the advancement of research.
South Africa